These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of food on oral melphalan absorption. Reece PA; Kotasek D; Morris RG; Dale BM; Sage RE Cancer Chemother Pharmacol; 1986; 16(2):194-7. PubMed ID: 3948305 [TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous/oral study using a conventional dose regimen. Woodhouse KW; Hamilton P; Lennard A; Rawlins MD Eur J Clin Pharmacol; 1983; 24(2):283-5. PubMed ID: 6840181 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma. Bosanquet AG; Gilby ED Eur J Cancer Clin Oncol; 1982 Apr; 18(4):355-62. PubMed ID: 6889512 [TBL] [Abstract][Full Text] [Related]
6. Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant disease. Tattersall MH; Jarman M; Newlands ES; Holyhead L; Milstead RA; Weinberg A Eur J Cancer (1965); 1978 May; 14(5):507-13. PubMed ID: 648565 [No Abstract] [Full Text] [Related]
7. Pharmacokinetics of high dose melphalan. Hersh MR; Ludden TM; Kuhn JG; Knight WA Invest New Drugs; 1983; 1(4):331-4. PubMed ID: 6678879 [TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of melphalan during intermittent therapy of multiple myeloma. Loos U; Musch E; Engel M; Hartlapp JH; Hügl E; Dengler HJ Eur J Clin Pharmacol; 1988; 35(2):187-93. PubMed ID: 3191937 [TBL] [Abstract][Full Text] [Related]
9. The disposition of intraperitoneal bleomycin, melphalan, and vinblastine in cancer patients. Alberts DS; Chen HS; Chang SY; Peng YM Recent Results Cancer Res; 1980; 74():293-9. PubMed ID: 6160601 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice. Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304 [TBL] [Abstract][Full Text] [Related]
11. Plasma melphalan and prednisolone concentrations during oral therapy for multiple myeloma. Taha IA; Ahmad RA; Gray H; Roberts CI; Rogers HJ Cancer Chemother Pharmacol; 1982; 9(1):57-60. PubMed ID: 7139852 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 cases. Ardiet C; Tranchand B; Biron P; Rebattu P; Philip T Cancer Chemother Pharmacol; 1986; 16(3):300-5. PubMed ID: 3516430 [TBL] [Abstract][Full Text] [Related]
13. Interaction of cimetidine with oral melphalan. A pharmacokinetic study. Sviland L; Robinson A; Proctor SJ; Bateman DN Cancer Chemother Pharmacol; 1987; 20(2):173-5. PubMed ID: 3311444 [TBL] [Abstract][Full Text] [Related]
14. Oral melphalan pharmacokinetics--relation to dose in patients with multiple myeloma. Ehrsson H; Eksborg S; Osterborg A; Mellstedt H; Lindfors A Med Oncol Tumor Pharmacother; 1989; 6(2):151-4. PubMed ID: 2747308 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of melphalan in children following high-dose intravenous injection. Taha IA; Ahmad RA; Rogers DW; Pritchard J; Rogers HJ Cancer Chemother Pharmacol; 1983; 10(3):212-6. PubMed ID: 6861266 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of high-dose melphalan in children and adults. Gouyette A; Hartmann O; Pico JL Cancer Chemother Pharmacol; 1986; 16(2):184-9. PubMed ID: 3948304 [TBL] [Abstract][Full Text] [Related]
17. Effect of L-leucine on oral melphalan kinetics in patients. Reece PA; Dale BM; Morris RG; Kotasek D; Gee D; Rogerson S; Sage RE Cancer Chemother Pharmacol; 1987; 20(3):256-8. PubMed ID: 3315285 [TBL] [Abstract][Full Text] [Related]
18. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects. Goren MP; Houle JM; Bush DA; Li JT; Newman CE; Brade WP Clin Cancer Res; 1998 Oct; 4(10):2313-20. PubMed ID: 9796960 [TBL] [Abstract][Full Text] [Related]